ORIGINAL RESEARCH
Published on 01 Apr 2026
The impact of the 2019 revision of China’s drug administration law on the innovative output of pharmaceutical and biotechnology enterprises—a quasi-natural experimental study using sharp regression discontinuity design
doi 10.3389/fmed.2026.1592775
- 1,444 views
